PE HUB Second Opinion
In Second Opinion, Cerberus and Sycamore are mulling a Staples buyout, the first "artificial pancreas" systems are coming to market and Apple is now worth more than $775 billion.
2 May 2017•1 min read
In Second Opinion, Cerberus and Sycamore are mulling a Staples buyout, the first "artificial pancreas" systems are coming to market and Apple is now worth more than $775 billion.
